This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) (CLARA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT06041256
Recruitment Status : Recruiting
First Posted : September 18, 2023
Last Update Posted : January 29, 2024
Information provided by (Responsible Party):
Aurion Biotech

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2024
Estimated Study Completion Date : October 2025